| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JCJD.2018.04.008 |
| P698 | PubMed publication ID | 30173928 |
| P2093 | author name string | Edward Etchells | |
| Elizabeth Tullis | |||
| Jenna Sykes | |||
| Julie A Gilmour | |||
| P2860 | cites work | The use of fructosamine in cystic fibrosis-related diabetes (CFRD) screening. | Q50925279 |
| Using HbA1c as a screening tool for Cystic Fibrosis Related Diabetes. | Q51577904 | ||
| HbA1c is not recommended as a screening test for diabetes in cystic fibrosis | Q73905088 | ||
| HbA1c: An effective screening tool for cystic fibrosis related diabetes? | Q86607625 | ||
| Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review | Q34351912 | ||
| Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society | Q34351928 | ||
| Hyperglycemia and death in cystic fibrosis-related diabetes. | Q35060271 | ||
| An introduction to power and sample size estimation | Q35211318 | ||
| Glargine versus NPH insulin in cystic fibrosis related diabetes | Q36710309 | ||
| Glucose tolerance in patients with cystic fibrosis: five year prospective study | Q36905808 | ||
| Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial | Q37364992 | ||
| Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues | Q38261885 | ||
| HbA1c as a screening tool for cystic fibrosis related diabetes | Q38419106 | ||
| Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes | Q38746353 | ||
| Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study | Q38910874 | ||
| Screening for Cystic Fibrosis-Related Diabetes: Matching Pathophysiology and Addressing Current Challenges | Q38979834 | ||
| Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis | Q44259350 | ||
| Glucose intolerance in children with cystic fibrosis | Q44313484 | ||
| Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. | Q45298887 | ||
| No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes | Q46315068 | ||
| Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis. | Q46637181 | ||
| Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes | Q46884875 | ||
| P433 | issue | 1 | |
| P921 | main subject | glycated hemoglobin | Q311213 |
| P304 | page(s) | 13-18 | |
| P577 | publication date | 2018-05-02 | |
| P1433 | published in | Canadian Journal of Diabetes | Q15816397 |
| P1476 | title | Cystic Fibrosis-Related Diabetes Screening in Adults: A Gap Analysis and Evaluation of Accuracy of Glycated Hemoglobin Levels | |
| P478 | volume | 43 |
| Q104141705 | 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021 |
| Q92161883 | 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020 |
| Q92887713 | Abnormal glucose tolerance and the 50-gram glucose challenge test in Cystic fibrosis |
| Q91466709 | How reliable is your HbA1c test? Revisiting the use of HbA1c in cystic fibrosis-related diabetes (CFRD) screening |
| Q91896737 | Incidence and risk factors of paediatric cystic fibrosis-related diabetes |
| Q91322272 | Validation of a Stepwise Approach Using Glycated Hemoglobin Levels to Reduce the Number of Required Oral Glucose Tolerance Tests to Screen for Cystic Fibrosis-Related Diabetes in Adults |
| Q91310409 | What is the Real Usefulness of Glycated Hemoglobin Levels for Diabetes Screening in Patients With Cystic Fibrosis? |
Search more.